#United States #Orlando #Connect Life Sciences #Megan Driscoll #PharmaLogics

Connect Life Sciences Moves Forward with New Leadership

Connect Life Sciences (CLS), a key player in the life sciences recruitment sector, has made a significant announcement regarding its leadership structure. The company has appointed Megan Driscoll as the new Executive Chairman of the Board of Directors. This pivotal move is anticipated to enhance the company’s strategic direction, enabling it to better assist its clients in the pharmaceutical, biotechnology, and medical device industries.

A Leader in Life Sciences Recruitment

Megan Driscoll's credentials as a leader in the life sciences recruitment field are exceptional. She founded PharmaLogics Recruiting in 2003, propelling it into one of the largest life sciences recruiting firms on the East Coast, boasting over 200 employees. Under her direction, PharmaLogics was named among the INC 5000 Fastest Growing Companies and was recognized as one of the Best Places to Work by the Boston Globe. In 2018, she received the accolade of Small Business CEO of the Year from the Boston Chamber of Commerce.

In 2017, Webster Equity Partners, a private equity firm focused on healthcare, acquired PharmaLogics, showcasing Driscoll's effective leadership and vision. Following this, she established Megan Driscoll Consulting, where she focuses on helping founders scale their businesses by incorporating AI-driven solutions tailored to their unique needs.

The Vision for Connect Life Sciences

Scott Dalton, CEO of Connect Life Sciences, expressed enthusiasm over Driscoll's appointment: "We are thrilled to welcome Megan as Executive Chairman. Her proven track record in building and growing a premier life sciences recruiting organization, coupled with her extensive industry relationships and operational expertise, make her a remarkable addition to our team. Megan’s insights and strategic perspective will be immensely beneficial as CLS continues to expand and enhance our offerings to clients."

Driscoll herself shared her excitement about her new role, noting: "I am thrilled to join Connect Life Sciences at such a crucial phase of the company’s growth. CLS has built a solid reputation in life sciences recruitment, and I'm eager to collaborate with the leadership team to drive further growth, enhance our capabilities, and maintain our commitment to delivering exceptional service to our clients and candidates in the industry."

Services Offered by Connect Life Sciences

Headquartered in Orlando, Florida, Connect Life Sciences offers a comprehensive suite of recruitment services aimed at addressing the diverse needs of the life sciences sector. From staff augmentation to project-based services, CLS delivers total life cycle resourcing solutions that include:

• - Contract Staffing
• - Contract to Hire
• - Direct Placement
• - Consulting Services

Their expertise encompasses all facets of the life sciences field, including research, regulatory affairs, biostatistics, data management, clinical monitoring, quality assurance, IT programming, pharmacovigilance, medical writing, and real-world evidence.

The Role of Argosy Healthcare Partners

Connect Life Sciences is a portfolio company of Argosy Healthcare Partners (AHP), a private equity firm that specializes in partnering with founder-owned healthcare companies across the United States, focusing on businesses with an EBITDA of $1.0 – $3.0 million. AHP aims to aid these companies in preserving their culture while fostering business reinvestment and accelerating growth to achieve their fullest potential.

In conclusion, Megan Driscoll's appointment as Executive Chairman signals an exciting new chapter for Connect Life Sciences. With her extensive experience and proven leadership in the industry, CLS is poised to enhance its role in the life sciences recruitment landscape, ensuring that they continue to meet the evolving needs of their clients effectively.